Jelena V Jovanovic

Jelena V Jovanovic

UNVERIFIED PROFILE

Are you Jelena V Jovanovic?   Register this Author

Register author
Jelena V Jovanovic

Jelena V Jovanovic

Publications by authors named "Jelena V Jovanovic"

Are you Jelena V Jovanovic?   Register this Author

11Publications

298Reads

12Profile Views

Assessment of Minimal Residual Disease in Standard-Risk AML.

N Engl J Med 2016 Feb 20;374(5):422-33. Epub 2016 Jan 20.

From the Molecular Oncology Unit and Cancer Genetics Laboratory, Department of Medical and Molecular Genetics, Guy's Hospital (A.I.), the Department of Medical and Molecular Genetics (M.A.S., J.V.J., E.S., D.G.) and Department of Asthma, Allergy and Respiratory Science (H.F., F.M.), Faculty of Life Sciences and Medicine, King's College London, the Department of Haematology, University College London (Y.P., D.C.L., R.E.G.), and the Innovation Department, Cancer Research UK (N.B.), London, the Experimental Cancer Medicine Centre (A. Gilkes) and Department of Haematology (R.K.H., A.K.B.), Cardiff University School of Medicine, and the Haematology Clinical Trials Unit, Cardiff University (A. Grech), Cardiff, West Midlands Regional Genetics Laboratory, Birmingham (J.M., K.W., S.A., M.G.), MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine and Department of Haematology, University of Oxford and Oxford University Hospitals NHS Trust, and the National Institute for Health Research Oxford Biomedical Research Centre (P.V.), Oxford, the Department of Clinical Immunology, University of Birmingham, Birmingham (S.D.F.), and the Centre for Clinical Haematology, Nottingham University Hospital, Nottingham (N.R.) - all in the United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1507471DOI Listing
February 2016

Can we say farewell to monitoring minimal residual disease in acute promyelocytic leukaemia?

Best Pract Res Clin Haematol 2014 Mar 12;27(1):53-61. Epub 2014 Apr 12.

Department of Haematology, Cardiff University, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2014.04.002DOI Listing
March 2014

Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemia.

Front Oncol 2011 25;1:35. Epub 2011 Oct 25.

Cancer Genetics Laboratory, Department of Medical and Molecular Genetics, King's College London School of Medicine London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2011.00035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356041PMC
August 2012

Development of minimal residual disease-directed therapy in acute myeloid leukemia.

Semin Oncol 2008 Aug;35(4):388-400

Departments of Immunology and Haematology, University of Birmingham, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2008.04.009DOI Listing
August 2008